Intravesicular cargo of microvesicles transferred to immune cells via CD36 can persist in these cells for extended time periods, and, thus, CD36 could potentially support the long-term reprogramming of cellular phenotypes relevant for tumor metastasis [66]. The gene discussed is CD36; the disease is neoplasm.